SCHEMBL7137229

SCHEMBL7137229

O=C1Nc2ccc(CCCl)cc2C1=Cc1cccc(O)c1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP3K7 O43318 1/20 0.50
TAB1 Q15750 1/20 0.50
PLK4 O00444 1/20 0.50
PLK1 P53350 1/20 0.50
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
PDPK1 O15530 2/20 0.43
CTRC Q99895 1/20 0.42
RAF1 P04049 2/20 0.42
LRRK2 Q5S007 6/20 0.41
PSEN1 P49768 2/20 0.41
PSEN2 P49810 2/20 0.41
APH1B Q8WW43 2/20 0.41
NCSTN Q92542 2/20 0.41
APH1A Q96BI3 2/20 0.41
PSENEN Q9NZ42 2/20 0.41
MAP1LC3B Q9GZQ8 1/20 0.41
PDGFRB P09619 1/20 0.40
PDGFRA P16234 1/20 0.40
FLT1 P17948 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5366299 0.89 LRRK2 (0.53) MAP3K7TAB1PLK4PLK1MEN1
SCHEMBL5359526 0.86 NPC1 (0.51) PLK4PLK1MEN1KMT2ALRRK2
SCHEMBL5374178 0.84 MAP3K7 (0.48) MAP3K7TAB1PLK4PLK1MEN1
SCHEMBL5363550 0.84 IGF1R (0.49) MAP3K7TAB1PLK4PLK1MEN1
SCHEMBL7139603 0.82 MEN1 (0.49) PLK4PLK1MEN1KMT2APDPK1
SCHEMBL7136229 0.82 MAP1LC3B (0.57) PLK4PLK1MEN1KMT2ARAF1
SCHEMBL5367186 0.82 LRRK2 (0.53) LRRK2PSEN1PSEN2APH1BNCSTN
SCHEMBL7137072 0.82 NPC1 (0.50) PLK4PLK1MEN1KMT2APDPK1
SCHEMBL7139419 0.81 MEN1 (0.67) PLK4PLK1MEN1KMT2APDPK1
SCHEMBL7136594 0.81 NPC1 (0.62) PLK4PLK1MEN1KMT2APDPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6506763-B2 Useful in prevention and treatment of protein kinase related disorders such as cancer SUGEN, INC. 2003-01-14 US disclosed
EP-0984930-A1 2-INDOLINONE DERIVATIVES AS MODULATORS OF PROTEIN KINASE ACTIVITY Sugen, Inc. (US) 2000-03-15 EP disclosed
WO-1998050356-A1 2-INDOLINONE DERIVATIVES AS MODULATORS OF PROTEIN KINASE ACTIVITY SUGEN, INC. (US) 1998-11-12 WO disclosed